Cargando…

Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study

OBJECTIVES: Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This study sought to determine the association between arterial p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Seth R., Sacha, Gretchen L., Siuba, Matthew T., Lam, Simon W., Reddy, Anita J., Duggal, Abhijit, Vachharajani, Vidula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826954/
https://www.ncbi.nlm.nih.gov/pubmed/35156051
http://dx.doi.org/10.1097/CCE.0000000000000634
_version_ 1784647532707577856
author Bauer, Seth R.
Sacha, Gretchen L.
Siuba, Matthew T.
Lam, Simon W.
Reddy, Anita J.
Duggal, Abhijit
Vachharajani, Vidula
author_facet Bauer, Seth R.
Sacha, Gretchen L.
Siuba, Matthew T.
Lam, Simon W.
Reddy, Anita J.
Duggal, Abhijit
Vachharajani, Vidula
author_sort Bauer, Seth R.
collection PubMed
description OBJECTIVES: Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This study sought to determine the association between arterial pH and blood pressure after vasopressin initiation in septic shock. DESIGN: This retrospective, multicenter, observational cohort study evaluated the association of arterial pH at the time of vasopressin initiation with hemodynamic response to vasopressin and change in catecholamine dose after vasopressin initiation. Hemodynamic response was defined as a catecholamine dose decrease with mean arterial pressure greater than or equal to 65 mm Hg at 6 hours after vasopressin initiation. SETTING: Patients from eight hospitals in a health system were evaluated. PATIENTS: Patients with septic shock initiated on vasopressin as a catecholamine adjunct between January 2012 and November 2017 were screened for inclusion. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 1,350 patients were included. At the time of vasopressin initiation patients were severely ill with arterial pH 7.28 ± 0.13, Sequential Organ Failure Assessment 14.1 ± 3.5, lactate 5.6 ± 4.6 mmol/L, and norepinephrine-equivalent catecholamine dose 32.3 ± 25.4 µg/min. After adjusting for lactate and Sequential Organ Failure Assessment with multivariable logistic regression, lower arterial pH was independently associated with lower odds of hemodynamic response to vasopressin (for each 0.1 unit arterial pH was below 7.40, response odds ratio 0.79; 95% CI, 0.72–0.87). For each 0.1 unit the pH was below 7.40 at vasopressin initiation, the norepinephrine-equivalent catecholamine dose increased by 1.5 µg/min (95% CI, 0.5–2.5 µg/min) at 1 hour, and increased by 2.5 µg/min (95% CI, 1.4–3.5 µg/min) at 6 hours after vasopressin initiation. CONCLUSIONS: Compared with higher arterial pH, patients with septic shock and low arterial pH had lower odds of vasopressin response and higher catecholamine doses after vasopressin initiation. Similar to other vasopressors, the clinical effectiveness of vasopressin appears to be impaired in the setting of acidemia.
format Online
Article
Text
id pubmed-8826954
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88269542022-02-10 Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study Bauer, Seth R. Sacha, Gretchen L. Siuba, Matthew T. Lam, Simon W. Reddy, Anita J. Duggal, Abhijit Vachharajani, Vidula Crit Care Explor Original Clinical Report OBJECTIVES: Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This study sought to determine the association between arterial pH and blood pressure after vasopressin initiation in septic shock. DESIGN: This retrospective, multicenter, observational cohort study evaluated the association of arterial pH at the time of vasopressin initiation with hemodynamic response to vasopressin and change in catecholamine dose after vasopressin initiation. Hemodynamic response was defined as a catecholamine dose decrease with mean arterial pressure greater than or equal to 65 mm Hg at 6 hours after vasopressin initiation. SETTING: Patients from eight hospitals in a health system were evaluated. PATIENTS: Patients with septic shock initiated on vasopressin as a catecholamine adjunct between January 2012 and November 2017 were screened for inclusion. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 1,350 patients were included. At the time of vasopressin initiation patients were severely ill with arterial pH 7.28 ± 0.13, Sequential Organ Failure Assessment 14.1 ± 3.5, lactate 5.6 ± 4.6 mmol/L, and norepinephrine-equivalent catecholamine dose 32.3 ± 25.4 µg/min. After adjusting for lactate and Sequential Organ Failure Assessment with multivariable logistic regression, lower arterial pH was independently associated with lower odds of hemodynamic response to vasopressin (for each 0.1 unit arterial pH was below 7.40, response odds ratio 0.79; 95% CI, 0.72–0.87). For each 0.1 unit the pH was below 7.40 at vasopressin initiation, the norepinephrine-equivalent catecholamine dose increased by 1.5 µg/min (95% CI, 0.5–2.5 µg/min) at 1 hour, and increased by 2.5 µg/min (95% CI, 1.4–3.5 µg/min) at 6 hours after vasopressin initiation. CONCLUSIONS: Compared with higher arterial pH, patients with septic shock and low arterial pH had lower odds of vasopressin response and higher catecholamine doses after vasopressin initiation. Similar to other vasopressors, the clinical effectiveness of vasopressin appears to be impaired in the setting of acidemia. Lippincott Williams & Wilkins 2022-02-08 /pmc/articles/PMC8826954/ /pubmed/35156051 http://dx.doi.org/10.1097/CCE.0000000000000634 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Clinical Report
Bauer, Seth R.
Sacha, Gretchen L.
Siuba, Matthew T.
Lam, Simon W.
Reddy, Anita J.
Duggal, Abhijit
Vachharajani, Vidula
Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title_full Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title_fullStr Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title_full_unstemmed Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title_short Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
title_sort association of arterial ph with hemodynamic response to vasopressin in patients with septic shock: an observational cohort study
topic Original Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826954/
https://www.ncbi.nlm.nih.gov/pubmed/35156051
http://dx.doi.org/10.1097/CCE.0000000000000634
work_keys_str_mv AT bauersethr associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT sachagretchenl associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT siubamatthewt associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT lamsimonw associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT reddyanitaj associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT duggalabhijit associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy
AT vachharajanividula associationofarterialphwithhemodynamicresponsetovasopressininpatientswithsepticshockanobservationalcohortstudy